ScripThe market for initial public offerings in the US looks like it might be waking up from a month and a half nap with one biopharmaceutical company making it through the IPO window in mid-June and three
ScripAfter its bid to acquire Canada's Bioasis Technologies, Inc. hit the rocks, UK group Biodexa Pharmaceuticals , formerly Midatech Pharma PLC , is looking to combine with Varian Biopharmaceuticals
ScripMidatech Pharma PLC ’s hopes of survival have been badly damaged by its own shareholders who have voted against the UK firm's proposed merger with Bioasis Technologies, Inc. . With cash reserves rapi
ScripWith cash rapidly running out, the UK's Midatech Pharma PLC hopes to have secured its future by merging with Bioasis Technologies, Inc. to create "a multi-asset rare and orphan disease company" th